linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth

Get access to free reads

Start Your Trial Start Your membership

Get 15-day free trial to all of ET Prime

Start Your Trial Start Your membership
Not a member
Already a member?
Not a member

Your membership

RENEW
ET Prime

India’s coronavirus vaccine pipeline could be one of the largest in the world

“Nationally, nearly 30 Covid-19 vaccine candidates are under development, by both industry and academia. These vaccines are in different stages of pre-clinical and clinical development,” said Harsh Vardhan, Union Minister for Health and Family Welfare, in the Lok Sabha last week.
Increase Font
Decrease Font
Cancel
20 Sep 2020 2 Mins Read 0 comment
There are 30 vaccine candidates in various stages of development AFP
There are 30 vaccine candidates in various stages of development
MUMBAI:India has three Covid-19 vaccine candidates in phase 2/3 human trials, with four more to start late-stage trials by end of the year, data from the World Health Organization (WHO), India’s health ministry and the clinical trial registry show. Besides, there are 30 vaccine candidates in various stages of development, making it one of the largest pipelines in the
next month. Besides these companies, Pune-based Gennova, Hyderabad-based Biological E and Aurobindo Pharma will start their human trials by end of the year. The National Institutes of Health earlier this month approved funding worth $8 million to India’s Gennova Biopharmaceuticals and US-based HDT to start pre-clinical and clinical activities to accelerate development of HDT-301, a Covid-19 vaccine candidate.
MUMBAI:India has three Covid-19 vaccine candidates in phase 2/3 human trials, with four more to start late-stage trials by end of the year, data from the World Health Organization (WHO), India’s health ministry and the clinical trial registry show. Besides, there are 30 vaccine candidates in various stages of development, making it one of the largest pipelines in the next month. Besides these companies, Pune-based Gennova, Hyderabad-based Biological E and Aurobindo Pharma will start their human trials by end of the year. The National Institutes of Health earlier this month approved funding worth $8 million to India’s Gennova Biopharmaceuticals and US-based HDT to start pre-clinical and clinical activities to accelerate development of HDT-301, a Covid-19 vaccine candidate.

The latest from ET Prime is now on Telegram. To subscribe to our Telegram newsletter click here.

Gift this story

YOU CAN GIFT 0 MORE STORIES THIS MONTH

Maximum 10 Email IDs allowed

300 characters remaining

Gift Sent Successfully

Limit Reached
Limit Reached

You’ve gifted all the 0 articles from your monthly gift bucket!

Please come back next month.

0 more articles will be waiting for you in your gift bucket.

Current Edition

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]